Intuitive Surgical Q3 Revenue Up 21.5%, Buybacks Offset Margin Pressure from Strategic Pricing Cuts
Intuitive Surgical reports strong Q3 growth but accepts short-term margin hits via price cuts to defend market share, supported by nearly $3B in share repurchases.
US surgical robotics company Intuitive Surgical reported third-quarter results showing 21.5% year-over-year revenue growth to just over $3 billion, beating consensus estimates by more than 400 basis points. Despite robust core performance, the company disclosed two impairments affecting margins: a one-time settlement related to a known class-action lawsuit and strategic pricing adjustments aimed at expanding its addressable market.
Management announced a reduction in per-procedure revenue by 3% to 5%, targeting high-volume procedures to compete against entrants like Medtronic and Johnson & Johnson. This strategy sacrifices some short-term profitability but is expected to be offset by increased procedure volumes, maintaining a healthy cash flow outlook. Adjusted net income rose 21.1% year-over-year, while adjusted EPS grew 25%, accelerated by share buybacks.
In terms of capital allocation, Intuitive Surgical executed nearly $3 billion in aggressive share repurchases during Q3, reducing the average share count by 2.8% compared to last year. The company does not pay dividends, opting for flexible buybacks to return capital. While cash balances declined due to repurchases and higher inventory, the balance sheet remains resilient.
The company narrowed its full-year revenue growth guidance to 14% to 15%, approximately 60 basis points below the midpoint of analyst expectations, but raised its profit forecast. Analysts note that institutional ownership remains stable and price targets are firming, suggesting the market is digesting temporary margin pressure while focusing on long-term market share defense and cash generation capabilities. However, the premium valuation above 40x P/E remains a risk factor if future earnings disappoint.